Beyond RVUs: Five 2027 Medicare Policies Physician Practices Should Be Modeling Now
Repricing your CPT volume under the proposed 2027 Medicare Physician Fee Schedule is an important exercise.
It is also incomplete.
The proposed rule includes several policies that cannot be fully measured by simply comparing 2026 and 2027 RVUs.
Some depend on which services are performed together.
Some depend on who performs the work.
Some depend on participation in an ACO.
And others signal potential reimbursement changes that may extend beyond 2027.
For physician executives and practice administrators, that means a complete Medicare risk assessment needs two layers:
Layer 1: Fee-schedule repricing
What happens to our CPTs, RVUs and conversion factor?
Layer 2: Policy exposure
What happens because of changes in billing rules, staffing requirements and payment methodology?
Here are five areas that deserve attention.
1. Same-day E/M and global procedures
This may be one of the most consequential operational proposals for procedure-heavy specialties.
For CY 2027, CMS is proposing to reduce payment when a separately identifiable office/outpatient E/M visit is furnished by the same physician — or a physician in the same practice — on the same day as a procedure with a 0-, 10- or 90-day global period.
Under the proposal:
The highest-cost affected service would be paid at 100%.
The other affected E/M visit or surgical procedure would be paid at 50%.
Think about what that means operationally.
A standard CPT-volume report cannot identify this exposure.
Why?
Because the financial impact depends on whether two services occurred:
for the same patient,
on the same date,
within the same practice,
and in the relevant global-procedure combination.
Practices in dermatology, otolaryngology, orthopedics, hand surgery, podiatry and other procedure-heavy specialties should consider running a patient/date-level pairing analysis.
A useful starting calculation is:
Annual qualifying same-day encounters × average allowed amount of the secondary service × 50%
That will not perfectly reproduce claims adjudication, but it can quickly establish whether the exposure is immaterial or potentially significant.
The key takeaway:
This risk does not necessarily appear in a CPT repricing model.
It needs a separate analysis.
2. RPM and RTM delivery models
Remote Physiologic Monitoring and Remote Therapeutic Monitoring have become meaningful revenue and care-management strategies for some practices.
The proposed 2027 rule could materially affect how those programs are operated.
CMS proposes that:
RTM be furnished only to established patients;
practitioners reporting RPM or RTM furnish a separately reportable initiating visit associated with the onset of the service; and
RPM/RTM clinical-staff services be payable only when performed by clinical staff employed by the practice, rather than contractor-delivered clinical staff.
CMS is also proposing valuation changes based partly on its view that device costs may now be lower than originally estimated.
For practices using third-party remote-monitoring vendors, this is not merely a reimbursement-rate question.
It is an operating-model question.
Leadership should understand:
Who owns the devices?
Who performs each clinical task?
Who employs the clinical staff?
Which activities are performed by contractors?
Who documents the initiating visit?
What percentage of existing RPM/RTM revenue depends on the current vendor structure?
If a meaningful portion of revenue depends on contractor-performed clinical-staff services, that revenue should be identified as a policy-risk bucket while the rule remains proposed.
3. G2211 may become a percentage-based modifier
CMS is also proposing a significant change to the office/outpatient E/M complexity add-on structure.
G2211 currently operates as a separately payable add-on code.
For 2027, CMS proposes transitioning G2211 to a modifier — currently referenced as MOD1 — that would increase payment for the associated E/M service by 16% rather than paying a flat amount.
CMS is also proposing a second modifier, MOD2, for eligible practitioners participating in the Medicare Shared Savings Program or the Long-term Enhanced ACO Design model. MOD2 would increase payment for the associated E/M visit by 32%.
That creates both opportunity and analytical complexity.
A primary-care or longitudinal specialty practice should not simply calculate:
Eligible E/M revenue × 16%
and call that the incremental benefit.
Why?
Because the proposed modifier would replace the existing G2211 payment structure.
The correct analysis compares:
Current E/M + G2211 economics
against
Proposed E/M + MOD1 or MOD2 economics.
The opportunity may vary by E/M level because a percentage-based modifier produces a different dollar amount at different base payments.
For ACO participants, the proposed MOD2 structure could also create a meaningful new reimbursement consideration.
This is exactly the type of policy where billing strategy, ACO participation and financial modeling intersect.
4. Practice Expense is becoming a strategic issue
Practice Expense is often treated as the less-visible part of Medicare reimbursement.
In 2027, it deserves much more attention.
CMS says it is engaged in a multi-year effort to reduce reliance on older specialty-specific PE/hour data and move toward more objective and routinely updated cost information.
The proposed methodology would phase out part of the current approach over several years and introduce a stabilizer intended to limit short-term volatility.
This matters for two reasons.
First, 2027 may not represent the fully implemented financial effect.
Some CPTs are subject to phase-in protections that reduce the immediate decline.
Second, the direction of future reimbursement could become increasingly sensitive to the actual cost assumptions CMS uses for:
clinical labor,
supplies,
equipment, and
indirect practice costs.
Practices should therefore distinguish between:
2027 proposed exposure
and
longer-term PE methodology exposure.
For capital-intensive or procedure-heavy specialties, that may become an increasingly important strategic consideration.
5. Global surgery is a future risk — even where no immediate broad cut is proposed
It is important to be precise here.
CMS is not proposing a blanket 2027 reduction to every 10- or 90-day global surgical package.
However, CMS is clearly continuing to evaluate whether current global surgical valuations accurately reflect the postoperative services actually being furnished.
CMS states that it has several years of data suggesting that postoperative visits included in global packages are not always occurring even though payment for those visits remains incorporated in the global payment.
For 2027, CMS proposes pausing the current MACRA data-collection requirement while soliciting comments on alternative data sources and potential approaches to future global-surgery revaluation. CMS is also publishing information estimating the RVUs associated with postoperative visits in 10- and 90-day global packages.
For surgery-heavy practices, this should be viewed as a strategic watch item.
It would be inappropriate to invent a 2027 revenue reduction that CMS has not proposed.
But it would be equally inappropriate to ignore the direction of the policy discussion.
Practices should begin understanding:
What percentage of Medicare revenue comes from 10- and 90-day globals?
How consistently are postoperative visits actually performed?
How are those visits documented?
Which procedure families would be most exposed if CMS ultimately revalues the postoperative component?
That is scenario planning — not forecasting.
There are opportunities in the proposed rule too
Not every policy represents downside.
CMS is proposing separate coding and payment for shared medical appointments, creating a potential new reimbursement pathway for group-based management of chronic conditions.
CMS is also proposing two new HCPCS codes for advance care planning performed by clinical staff under direct supervision, while proposing that existing CPT codes 99497 and 99498 represent practitioner time.
For organizations with appropriate patient populations and workflows, these may create new service opportunities.
The strategic question should therefore not be:
“What is Medicare cutting?”
It should be:
“Where is Medicare changing the economics or operating requirements of care delivery?”
That is a much broader question.
What should practices do before 2027?
A useful Medicare policy-readiness process would include:
1. Reprice the CPT portfolio.
Understand the base 2026-to-2027 reimbursement and wRVU change.
2. Pair same-day E/M and global procedure claims.
Identify modifier-25 exposure that a CPT summary cannot capture.
3. Map RPM/RTM staffing.
Separate employed clinical staff from contractor-delivered activity.
4. Model G2211/MOD1/MOD2.
Evaluate the economics by E/M level and ACO participation.
5. Quantify global-surgery concentration.
Treat this as a future-policy sensitivity, not a fabricated 2027 cut.
6. Examine PE phase-in.
Identify services where the proposed 2027 result may understate longer-term exposure.
At Appalachian Physician Advisors, we built the 2027 Policy Risk Analyzer specifically to help practices work through these questions.
It is designed to complement — not duplicate — the Practice Impact Analyzer.
The Practice Impact Analyzer answers:
“What does the proposed fee schedule do to our CPT mix?”
The Policy Risk Analyzer asks:
“What financial or operational risks are not visible in the CPT rates?”
Together, those two questions provide a much more complete picture of 2027 Medicare exposure.
CMS's proposed rule remains open for public comment through September 14, 2026.
Some proposals may change before the final rule.
But waiting for the final rule to begin the analysis leaves very little time to change contracts, staffing models, workflows or budgets before January 1.
The fee schedule tells you what Medicare proposes to pay.
Policy determines how the economics actually reach your practice.
Explore the APA 2027 Policy Risk Analyzer and the complete Medicare Intelligence toolkit at APAHealthcare.com.
Source: CMS CY 2027 Medicare Physician Fee Schedule Proposed Rule, CMS-1848-P. All 2027 policies and rates discussed are proposed and subject to change in the final rule.
Comments